Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway.
| Author | |
|---|---|
| Year of Publication |    :  
                  2018 
             | 
        
| Journal |    :  
                  Investigational new drugs 
             | 
        
| Date Published |    :  
                  2018 
             | 
        
| ISSN Number |    :  
                  0167-6997 
             | 
        
| DOI |    :  
                  10.1007/s10637-017-0558-5 
             | 
        
| Short Title |    :  
                  Invest New Drugs 
             | 
        
| Download citation |